New York State Teachers Retirement System Sells 2,225 Shares of Teleflex Incorporated (NYSE:TFX)

New York State Teachers Retirement System lowered its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 44,889 shares of the medical technology company’s stock after selling 2,225 shares during the period. New York State Teachers Retirement System’s holdings in Teleflex were worth $11,193,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. Commonwealth Equity Services LLC lifted its holdings in shares of Teleflex by 0.9% during the 1st quarter. Commonwealth Equity Services LLC now owns 4,688 shares of the medical technology company’s stock valued at $1,187,000 after purchasing an additional 42 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of Teleflex by 33.3% during the 4th quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after purchasing an additional 46 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its holdings in shares of Teleflex by 3.5% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 1,411 shares of the medical technology company’s stock valued at $284,000 after purchasing an additional 48 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in shares of Teleflex by 39.1% during the 1st quarter. First Horizon Advisors Inc. now owns 178 shares of the medical technology company’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Finally, Huntington National Bank lifted its holdings in shares of Teleflex by 26.5% during the 3rd quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock valued at $50,000 after purchasing an additional 53 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 2.5 %

NYSE:TFX opened at $218.24 on Thursday. The firm has a market capitalization of $10.28 billion, a price-to-earnings ratio of 28.98, a price-to-earnings-growth ratio of 2.08 and a beta of 1.11. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $276.43. The stock’s 50 day moving average price is $230.87 and its two-hundred day moving average price is $224.74. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, topping the consensus estimate of $3.26 by $0.12. The firm had revenue of $773.90 million for the quarter, compared to analyst estimates of $769.01 million. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.52 EPS. Equities research analysts expect that Teleflex Incorporated will post 13.73 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.62%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio (DPR) is 18.06%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on TFX. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Royal Bank of Canada cut their price objective on Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Raymond James boosted their target price on Teleflex from $227.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, December 20th. JMP Securities restated a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a research note on Friday, February 23rd. Finally, Truist Financial cut their target price on Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research note on Friday, February 23rd. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Teleflex currently has a consensus rating of “Moderate Buy” and a consensus target price of $265.56.

Insiders Place Their Bets

In related news, VP Cameron P. Hicks sold 7,401 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.41% of the company’s stock.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.